IDEAS home Printed from
MyIDEAS: Log in (now much improved!) to save this paper

Estudio sobre la propiedad intelectual en el sector farmacéutico colombiano

Listed author(s):
  • Emilio Archila


  • Gabriel Carrasquilla


  • Marcela Meléndez


  • Juan Pablo Uribe


Este estudio tiene un doble propósito. Por una parte, busca establecer el impacto que ha tenido el régimen de protección de propiedad intelectual (en adelante, régimen de protección) que aplica al sector farmacéutico en Colombia sobre el costo y el acceso a los medicamentos, a la luz de los datos disponibles. Por otra, busca entregar elementos para evaluar a futuro el impacto qué podrían tener modificaciones a ese régimen de protección. La aproximación metodológica es de carácter empírico. La mayor parte del trabajo que se presenta es descriptiva y tiene el propósito de contribuir a dimensionar adecuadamente el mercado de farmacéuticos en Colombia desde ángulos diversos. Adicionalmente, se presenta un ejercicio estadístico que arroja luz acerca del proceso de formación de precios en el mercado farmacéutico. No se presentan simulaciones del desempeño futuro del mercado, pero sí se revisan los elementos que serán claves para el mismo. El foco de atención es la salud de los colombianos. Este estudio no considera el impacto que el régimen de protección pueda haber tenido, tenga o pueda llegar a tener, sobre la industria farmacéutica en el mercado nacional.

If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL:
Download Restriction: no

Paper provided by FEDESARROLLO in its series INFORMES DE INVESTIGACIÓN with number 002622.

in new window

Length: 78
Date of creation: 30 Mar 2006
Handle: RePEc:col:000124:002622
Contact details of provider:

References listed on IDEAS
Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:

in new window

  1. Lanjouw, J.O., 1997. "The Introduction of Pharmaceutical Product Patents in India: "Heartless Exploitation of the Poor and Suffering"?," Papers 775, Yale - Economic Growth Center.
  2. En collaboration., 1990. "Strengthening protection of intellectual property in developing countries," World Bank - Discussion Papers 112, World Bank.
  3. Jean O. Lanjouw, 2005. "Patents, Price Controls and Access to New Drugs: How Policy Affects Global Market Entry," Working Papers 61, Center for Global Development.
Full references (including those not matched with items on IDEAS)

This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

When requesting a correction, please mention this item's handle: RePEc:col:000124:002622. See general information about how to correct material in RePEc.

For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Lucía Fenney Pérez)

If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

If references are entirely missing, you can add them using this form.

If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

Please note that corrections may take a couple of weeks to filter through the various RePEc services.

This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.